pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07383974: The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

Sponsor: ChinaNorm. Phase: NA. Conditions: Healthy Volunteers, Dietary Supplementation, Skin Health, Health Status, Antioxidants

full page →ctgov ↗
›COMPLETEDphase readoutNCT06713174: Interleukin 8 and10 Levels Changes in Teeth With Necrotic Pulp and Apical Periodontitis

Sponsor: Faculty of Dental Medicine for Girls. Phase: NA. Conditions: Pulp and Periapical Tissue Disease, Patients With Pulp Necrosis and Apical Periodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06244290: Dentinal Hypersensitivity Reduction

Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Dentinal Hypersensitivity

full page →ctgov ↗
›RECRUITINGphase readoutNCT05128890: Evaluation of Resection Techniques for Pancreatic Tumors

Sponsor: Methodist Health System. Phase: . Conditions: Surgery, Liver Tumor, Pancreas Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06406790: CraniSeal Post Approval Study

Sponsor: Pramand LLC. Phase: PHASE4. Conditions: Leak, Cerebrospinal Fluid

full page →ctgov ↗
›RECRUITINGphase readoutNCT02596490: Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01520597: National Study on Listeriosis and Listeria

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Listeriosis, Pregnancy Complications, Infectious, Central Nervous System Infections, Septicemia, Sepsis; Listeria Monocytogenes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05408013: The Prevalence of Insomnia in Patients With Psychiatric Disorders

Sponsor: University of Bern. Phase: . Conditions: Insomnia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06138613: Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Motion Sickness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07018713: A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Sponsor: Merz Therapeutics GmbH. Phase: PHASE3. Conditions: Chronic Migraine

full page →ctgov ↗
›COMPLETEDphase readoutNCT05599620: Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Sponsor: Lifespan. Phase: NA. Conditions: Alcohol Use, Unspecified, Sexual Dysfunction, Sexual Assault

full page →ctgov ↗
›RECRUITINGphase readoutNCT05746182: Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Sponsor: University of California, San Francisco. Phase: . Conditions: Pancreatic Neuroendocrine Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01599559: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: NA. Conditions: Primary Mediastinal B-cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06768359: The Effect of Manual Acupuncture and Standard Therapy on Anxiety and Quality of Life Scores in Cancer Patients

Sponsor: Indonesia University. Phase: NA. Conditions: Anxiety, Quality of Life, Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04340180: Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Sponsor: University of Alabama at Birmingham. Phase: PHASE1. Conditions: Breast Benign Tumor, Breast Malignant Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07220096: Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05928403: Rate of Return to Sport After Total Knee Prosthesis: Comparison of Three Types of Prostheses

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche. Phase: . Conditions: Knee Arthropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06245603: A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

Sponsor: Istituto Oncologico Veneto IRCCS. Phase: NA. Conditions: Non-muscle Invasive Bladder Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07136103: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants

Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›AVAILABLEphase readoutNCT05795361: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Sponsor: Takeda. Phase: . Conditions: Hunter Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07538661: Metabolic Regeneration Registry for Periodontal Health (20-Patient Cohort).

Sponsor: Amar h Zireg. Phase: . Conditions: Chronic Periodontitis, Chronic Periodontitis Wth Diabetes Mellitus, Non-surgical Periodontal Treatment, Gingival Regeneration, Metabolic Repair

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07386561: Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty

Sponsor: Wroclaw University of Health and Sport Sciences. Phase: NA. Conditions: Arthropathy, Osteoarthritis, Hip, Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07032662: IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sponsor: Immunovant Sciences GmbH. Phase: PHASE2. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03868670: Responsive Neurostimulation For Loss Of Control Eating

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Loss of Control Eating, Obesity, Morbid

full page →ctgov ↗
›RECRUITINGphase readoutNCT06069973: Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

Sponsor: Sahlgrenska University Hospital. Phase: . Conditions: Ischemic Stroke, Hemorrhagic Stroke

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07422727: Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy

Sponsor: Sligo General Hospital. Phase: NA. Conditions: Hot Flashes, Sleep, Hormonal, Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07458061: Kamuvudine-9 (K9) in Diabetic Macular Edema

Sponsor: Dr. Bryan Strelow. Phase: PHASE1. Conditions: Diabetic Macular Edema

full page →ctgov ↗
›COMPLETEDphase readoutNCT07408661: Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients

Sponsor: Tongji University. Phase: . Conditions: Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02811861: Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Sponsor: Eisai Inc.. Phase: PHASE3. Conditions: Renal Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05947279: Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Motor Adaptation and Generalization, Posterior Parietal Cortex, Cerebellum

full page →ctgov ↗
›COMPLETEDphase readoutNCT06161480: Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium

Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Delirium

full page →ctgov ↗
›COMPLETEDphase readoutNCT01164462: Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: NA. Conditions: HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07175662: Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

Sponsor: Newish Biotech (Wuxi) Co., Ltd.. Phase: PHASE2. Conditions: High-grade Squamous Intraepithelial Lesion (HSIL)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05613088: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Neoplasms, Ovarian

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07290179: Evaluating the Validity and Feasibility of a Smartwatch-based Eating Detection System to Passively and Automatically Detect Eating Events in Child-parent Dyads

Sponsor: Pennington Biomedical Research Center. Phase: . Conditions: Eating Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT07386379: Propofol Infusion and PONV in Cardiac Surgery

Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Postoperative Nausea and Vomiting, Cardiovascular Surgical Procedures

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07327996: Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial

Sponsor: Future University in Egypt. Phase: NA. Conditions: Necrotic Pulp

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06995703: Increasing Screening for Cancer Using EHR-Nudges Replication

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504003: Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Endurance Exercise, Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07226661: Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Sponsor: Supernus Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03897361: Stem Cell Gene Therapy for Cystinosis

Sponsor: University of California, San Diego. Phase: PHASE1. Conditions: Lysosomal Storage Diseases, Cystinosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06675461: Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Borderline Personality Disorder (BPD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT04763161: Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Ischemic Cerebrovascular Accident

full page →ctgov ↗
›RECRUITINGphase readoutNCT06698003: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma, T-cell Leukemia, Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07050927: Long-Term Effect of Online Occupational Therapy-Based Parent Training on Feeding Problems in Infants

Sponsor: Ankara Medipol University. Phase: NA. Conditions: Feeding Difficulties, Feeding Problems, Food Neophobia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07542561: AI-Assisted Mindfulness Intervention in Emotional Distress

Sponsor: Xinghua Liu. Phase: NA. Conditions: Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06512961: Applicability of Tissue Flossing for Blood Flow Restriction in the Upper Limb: Reliability and Performance Analysis

Sponsor: Paulista University. Phase: NA. Conditions: Hypertrophy, Muscle Strength

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06480461: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd.. Phase: PHASE1. Conditions: Parkinson's Disease

full page →ctgov ↗
›WITHHELDphase readoutNCT06709261: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333742: A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

Sponsor: LG Chem. Phase: PHASE1. Conditions: Fed Conditions, Healthy Volunteer

full page →ctgov ↗
← prev
page 65 of 158
next →